These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36585757)

  • 1. The use of certolizumab pegol to successfully treat generalized pustular psoriasis combined with psoriatic uveitis.
    Yatsuzuka K; Matsumoto T; Sakane Y; Fukaura R; Takeichi T; Akiyama M; Murakami M
    J Dermatol; 2023 Jun; 50(6):e175-e176. PubMed ID: 36585757
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized pustular psoriasis in pregnancy, successfully treated with certolizumab pegol.
    Mizutani Y; Mizutani YH; Matsuyama K; Kawamura M; Fujii A; Shu E; Ohnishi H; Seishima M
    J Dermatol; 2020 Jul; 47(7):e262-e263. PubMed ID: 32363682
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of Certolizumab Pegol in the Treatment of Psoriasis in a Cohort of Patients With Psoriatic Arthritis.
    Reina D; Vidal D
    Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):704-705. PubMed ID: 32593595
    [No Abstract]   [Full Text] [Related]  

  • 4. Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis.
    Esposito M; Carubbi F; Giunta A; Alunno A; Giacomelli R; Fargnoli MC
    Expert Rev Clin Immunol; 2020 Feb; 16(2):119-128. PubMed ID: 31917928
    [No Abstract]   [Full Text] [Related]  

  • 5. PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol.
    Walsh JA; Arledge T; Nurminen T; Peterson L; Stark J
    J Rheumatol; 2018 Jul; 45(7):922-928. PubMed ID: 29717036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis.
    Carubbi F; Fidanza R; Palmieri M; Ventura A; Tambone S; Cipriani P; Giacomelli R; Fargnoli MC
    J Dermatolog Treat; 2020 Nov; 31(7):692-697. PubMed ID: 30963798
    [No Abstract]   [Full Text] [Related]  

  • 7. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.
    Cauli A; Piga M; Lubrano E; Marchesoni A; Floris A; Mathieu A
    J Rheumatol Suppl; 2015 Nov; 93():70-2. PubMed ID: 26523062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nail Psoriasis Treated With Certolizumab Pegol in Patients With Psoriatic Arthritis: Preliminary Observation.
    Mazzeo M; Dattola A; Cannizzaro MV; Bianchi L
    Actas Dermosifiliogr (Engl Ed); 2019 Mar; 110(2):169-171. PubMed ID: 29866366
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report.
    Lu J; Tang S; Yu N; Yi X; Li Y
    J Int Med Res; 2020 Nov; 48(11):300060520969494. PubMed ID: 33161790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab pegol for the treatment of psoriasis.
    Campanati A; Benfaremo D; Luchetti MM; Ganzetti G; Gabrielli A; Offidani A
    Expert Opin Biol Ther; 2017 Mar; 17(3):387-394. PubMed ID: 28165828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of certolizumab pegol in cutaneous symptoms on psoriasis in patients with psoriatic arthritis: A retrospective analysis in real life.
    Dattola A; Mazzeo M; Di Stefano F; Manfreda V; Vollono L; Di Raimondo C; Di Matteo E; Bianchi L
    Dermatol Ther; 2020 May; 33(3):e13409. PubMed ID: 32291887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.
    Walsh JA; Gottlieb AB; Hoepken B; Nurminen T; Mease PJ
    Clin Rheumatol; 2018 Dec; 37(12):3285-3296. PubMed ID: 30191421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection.
    Ohmura SI; Homma Y; Hanai S; Miyamoto T
    Intern Med; 2022 Feb; 61(3):433-438. PubMed ID: 34803106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis.
    Lee A; Scott LJ
    BioDrugs; 2020 Apr; 34(2):235-244. PubMed ID: 32207094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for generalized pustular psoriasis: A case-control study.
    Mastacouris N; Feda A; Strunk A; Garg A
    J Am Acad Dermatol; 2023 Oct; 89(4):846-848. PubMed ID: 37331632
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials.
    Curtis JR; Mariette X; Gaujoux-Viala C; Blauvelt A; Kvien TK; Sandborn WJ; Winthrop K; de Longueville M; Huybrechts I; Bykerk VP
    RMD Open; 2019; 5(1):e000942. PubMed ID: 31245056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
    Deeks ED
    BioDrugs; 2016 Dec; 30(6):607-617. PubMed ID: 27704400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimzia™ (Certolizumab Pegol).
    Abramovits W; Wiqas A; Vincent KD; Versteeg SG; Gupta AK
    Skinmed; 2018; 16(6):400-402. PubMed ID: 30575508
    [No Abstract]   [Full Text] [Related]  

  • 19. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
    Corbett M; Chehadah F; Biswas M; Moe-Byrne T; Palmer S; Soares M; Walton M; Harden M; Ho P; Woolacott N; Bojke L
    Health Technol Assess; 2017 Oct; 21(56):1-326. PubMed ID: 28976302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Certolizumab pegol in pregnant and breastfeeding psoriatic patients.
    Lambiase S; Pensa C; Shumak RG; Bianchi L; Dattola A
    Ital J Dermatol Venerol; 2022 Aug; 157(4):383-384. PubMed ID: 35274878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.